HOLO BIO

Holo-Bio operates in the biotechnology sector, focusing on the discovery and utilization of local microbes to enhance the production of eicosapentaenoic acid (EPA) in organisms. The company serves clients in the healthcare and pharmaceutical industries, offering cutting-edge solutions derived from unique intestinal bacteria found in natural environments like Lake Isoza and Lake Sakura in Japan. Holo-Bio's business model revolves around research and development, leveraging advanced molecular biology techniques to transform unknown biological functions into practical applications. The company generates revenue through partnerships, licensing agreements, and direct sales of its biotechnological innovations. By combining intellectual expertise in molecular biology with the latest technologies, Holo-Bio aims to support societal needs through innovative biological research.

Keywords: biotechnology, EPA production, intestinal bacteria, molecular biology, healthcare, pharmaceuticals, research, development, licensing, innovation.